Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 5, 2013, Pages 388.e1-388.e10

  Bytautiene, Egle ^a   Bulayeva, Nataliya ^b   Bhat, Geeta ^a   Li, Li ^b   Rosenblatt, Kevin P ^b   Saade, George R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

maternal long term health; mice; preeclampsia; sFlt1

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G2A; PROTEIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DELIVERY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FISHER EXACT TEST; HEMATOLOGIC DISEASE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATERNAL CARE; MATERNAL PLASMA; METABOLIC DISORDER; MOUSE; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; TANDEM MASS SPECTROMETRY; VASCULAR DISEASE;

EID: 84876667554     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.01.042     Document Type: Article

References (24)

1. Y. Giguère, M. Charland, S. Thériault Linking preeclampsia and cardiovascular disease later in life Clin Chem Lab Med 50 2012 985 993
2. P.R. Romundstad, E.B. Magnussen, G.D. Smith, L.J. Vatten Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 122 2010 579 584
3. F. Lu, M. Longo, E. Tamayo The effect of over-expression of SFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice Am J Obstet Gynecol 196 2007 396.e1 396.e7
4. E. Bytautiene, F. Lu, E.H. Tamayo Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia Am J Physiol Heart Circ Physiol 298 2010 H189 H193
5. A.M. Ingalis, M.M. Dickie, G.D. Snell Obese, a new mutation in the house mouse J Hered 41 1950 317 318
6. E. Anuurad, M. Yamasaki, N. Shachter, T.A. Pearson, L. Berglund ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans J Lipid Res 50 2009 1472 1478
7. R.X. Li, Y.B. Ding, S.L. Zhao Secretome-derived isotope tags (SDIT) reveal adipocyte-derived apolipoprotein C-I as a predictive marker for cardiovascular disease J Proteome Res 11 2012 2851 2862
8. F. Borthwick, S. Warnakula, R. Mangat ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance Atherosclerosis 222 2012 402 408
9. D.J. Bennett, A.J. Cooke, A.S. Edwards Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis Recent Pat Cardiovasc Drug Disc 1 2006 21 46
10. A. Fraser, S.M. Nelson, C. Donald-Wallis Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age/clinical perspective Circulation 125 2012 1367 1380
11. S. He Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia Thromb Haemost 81 1999 538 542
12. J.T. Drost, G. Arpaci, J.P. Ottervanger Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM) Eur J Prev Cardiol 19 2012 1138 1144
13. J.M. Roberts, K.Y. Lain Recent insights into the pathogenesis of pre-eclampsia Placenta 23 2002 359 372
14. J.M. Roberts, D.W. Cooper Pathogenesis and genetics of pre-eclampsia Lancet 357 2001 53 56
15. M.T. Gervasi, T. Chaiworapongsa, P. Pacora Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia Am J Obstet Gynecol 185 2001 792 797
16. C.W.G. Redman, G.P. Sacks, I.L. Sargent Preeclampsia: an excessive maternal inflammatory response to pregnancy Am J Obstet Gynecol 180 1999 499 506
17. D.M. Shah Role of the renin-angiotensin system in the pathogenesis of preeclampsia Am J Physiol Renal Physiol 288 2005 F614 F625
18. J. Bohlender, D. Ganten, F.C. Luft Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension J Am Soc Nephrol 11 2000 2056 2061
19. K. De Boer, J.W. ten Cate, A. Sturk, J.J. Borm, P.E. Treffers Enhanced thrombin generation in normal and hypertensive pregnancy Am J Obstet Gynecol 160 1989 95 100
20. Y. Bdolah, V.P. Sukhatme, S.A. Karumanchi Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights Semin Nephrol 24 2004 548 556
21. S.E. Maynard, J.Y. Min, J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
22. R. Thadhani, W.P. Mutter, M. Wolf First Trimester Placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
23. G.C. McKeeman, J.E.S. Ardill, C.M. Caldwell, A.J. Hunter, N. McClure Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop Am J Obstet Gynecol 191 2004 1240 1246
24. R.J. Levine, S.E. Maynard, C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683